Citation Impact
Citing Papers
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
1990 StandoutNature
Focal Stimulation of the Mossy Fibers Releases Endogenous Dynorphins That Bind K1‐Opioid Receptors in Guinea Pig Hippocampus
1991
Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence
2001
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Modulation of humoral immune responses in the rat by centrally applied Met–Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors
2000
Modulation of anxiety through blockade of anandamide hydrolysis
2002 Standout
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates
1998
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
Descending control of pain
2002 Standout
Glutamate uptake
2001 Standout
Control of pain initiation by endogenous cannabinoids
1998 StandoutNature
Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue
1994 StandoutNobel
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
2004 StandoutNobel
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression
1999
FMRF-NH2-like mammalian octapeptide: Possible role in opiate dependence and abstinence
1990
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Determination of the Amino Acid Residue Involved in [3H]β-Funaltrexamine Covalent Binding in the Cloned Rat µ Opioid Receptor
1996
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
A review of the role of anti‐opioid peptides in morphine tolerance and dependence
1992
Psychedelics
2016 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
2015 Standout
Role of Hippocampal CA3 μ-Opioid Receptors in Spatial Learning and Memory
2004
G protein coupled receptor dimerization: implications in modulating receptor function
2001
Phencyclidine in the Social Interaction Test: An Animal Model of Schizophrenia with Face and Predictive Validity
1999
Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization
2002
Mismatches between neurotransmitter and receptor localizations in brain: observations and implications
1987
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
G Protein-coupled Receptors
1998 StandoutNobel
Hippocampal μ-receptors mediate opioid reinforcement in the CA3 region
1991
Cocaine alters opiate receptor binding in critical brain reward regions
1989
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
1989
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Interaction of Co-Expressed μ- and δ-Opioid Receptors in Transfected Rat Pituitary GH3Cells
2001
Hypertolerance to morphine in Gzα-deficient mice
2000
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study
1999
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
1991 Standout
The molecular logic of endocannabinoid signalling
2003 Standout
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
2012 StandoutNatureNobel
Dynorphin A increases substance P release from trigeminal primary afferent C-fibers
1999
Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands
1997
Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes
2002 StandoutNobel
Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer
1994
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Structure of the δ-opioid receptor bound to naltrindole
2012 StandoutNatureNobel
Dimerization of the δ Opioid Receptor:
1997
Oligomerization of μ- and δ-Opioid Receptors
2000
Metabolic Pathways and Potencies of New Fentanyl Analogs
2019
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Dopamine, learning and motivation
2004 Standout
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival
2007 Standout
Spatial learning with unilateral and bilateral hippocampal networks
2005 StandoutNobel
The Role and Regulation of Adenosine in the Central Nervous System
2001 Standout
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
The Glutamate Hypothesis of Schizophrenia
1997
Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
1997
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019
2021 Standout
A presynaptic locus for long-term potentiation of elementary synaptic transmission at mossy fiber synapses in culture.
1996 StandoutNobel
Recent developments in indole ring synthesis—methodology and applications
2000 Standout
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
2000 StandoutNatureNobel
Molecular Docking Reveals a Novel Binding Site Model for Fentanyl at the μ-Opioid Receptor
2000
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
Computational design of environmental sensors for the potent opioid fentanyl
2017 StandoutNobel
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia1Published on the World Wide Web on 12 January 1998.1
1998
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Cannabinoid receptor localization in brain.
1990 Standout
δ Opioid Affinity and Selectivity of 4-Hydroxy-3-methoxyindolomorphinan Analogues Related to Naltrindole
1999
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
1992 StandoutScience
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
1999 Standout
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
1991 Standout
Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor.
1994
Opioid Complications and Side Effects
2008 Standout
Molecular Mechanisms and Regulation of Opioid Receptor Signaling
2000
Identification of an Opioid κ Receptor Subtype-Selective N-Substituent for (+)-(3R,4R)-Dimethyl-4-(3-hydroxyphenyl)piperidine
1998
Hallucinogens
2004 Standout
Excitatory Amino Acid Receptors in Schizophrenia
1993
Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates
1990
Works of Victor Bykov being referenced
Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence
1991
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain
1990
Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: further evidence for two μ-binding sites
1989
Chronic administration of morphine and naltrexone up-regulate[3H][d-ala2,d-leu5]enkephalin binding sites by different mechanisms
1988
Interaction of β‐funaltrexamine with [3H]cycloFOXY binding in rat brain: Further evidence that β‐FNA alkylates the opioid receptor complex
1991
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that μ ligands are noncompetitive inhibitors of the δcx opioid peptide binding site
1992
Pharmacological activities of optically pure enantiomers of the κ opioid agonist, U50,488, and its cis diastereomer: evidence for three κ receptor subtypes
1989
Interaction of enantiomeric pairs of opiates with phencyclidine binding sites in rat brain: Identification of (+) pentazocine as a ligand potentially suitable for imaging sigma binding sites using positron emission tomography
1988
Chronic morphine upregulates a μ-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography
1987
The potent opioid agonist, (+)-cis-3-methylfentanyl binds pseudoirreversibly to the opioid receptor complex in vitro and in vivo: Evidence for a novel mechanism of action
1990
A study of the effect of the irreversible delta receptor antagonist [d-Ala2,Leu5,Cys6]Enkephalin on and opioid binding sites in vitro and in vivo
1992
Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences
1992
Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: Optimization of assay conditions
1985
Chronic haloperidol treatment up-regulates rat brain PCP receptors
1987
beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
1988